Graphene has already proven its importance to brain implants as well as other Synbio technology.
By interfacing brain cells with graphene, University of Illinois at Chicago researchers have differentiated a single hyperactive Glioblastoma Multiforme cancerous astrocyte cell from a normal cell in the lab — pointing the way to developing a simple, noninvasive tool for early cancer diagnosis.
In the study, reported in the journal ACS Applied Materials & Interfaces, the researchers looked at lab-cultured human brain astrocyte cells taken from a mouse model. They compared normal astrocytes to their cancerous counterpart, highly malignant brain tumor glioblastoma multiforme.
Comments are closed.